Caris Life Sciences (CAI) total liabilities

Total liabilities · fiscal 2025
$548.36M

Caris Life Sciences (CAI) had total liabilities of $548.36M at the end of fiscal 2025 (December 31, 2025). That is 80.7% lower than the $2.84B of fiscal 2024. Figures as of 19 Nov 2026, 11:41 UTC, from Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$548.36M
Change on fiscal 2024
−80.7%
Highest on record
$2.84Bfiscal 2024
Lowest on record
$548.36Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Caris Life Sciences total liabilities, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $2.84B in fiscal 2024 and the lowest $548.36M in fiscal 2025.

History · 4 fiscal years

Total liabilities by fiscal year

Caris Life Sciences total liabilities, year by year

Caris Life Sciences (CAI) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$548.36M 80.7% down
2024$2.84B 11.1% up
2023$2.56B 5.7% up
2022$2.42B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Caris Life Sciences and comparable companies
CompanyTotal liabilitiesFiscal year
Cytokinetics CYTK$2.08B2025
ABIVAX ABVX€129.14M2025
Bausch + Lomb BLCO$7.50B2025
Amneal Pharmaceuticals AMRX$3.75B2025
Caris Life Sciences CAI$548.36M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CAI

Caris Life Sciences, figure by figure

Caris Life Sciences (CAI) overview: price, valuation and scorecardAll health care companies by market value

Caris Life Sciences total liabilities: questions and answers

How large are Caris Life Sciences's total liabilities?

Caris Life Sciences (CAI) had total liabilities of $548.36M at the end of fiscal 2025 (December 31, 2025). That is 80.7% lower than the $2.84B of fiscal 2024.

What are the highest and lowest total liabilities figures on record for Caris Life Sciences?

Across the 4 fiscal years on record (2022–2025), the highest was $2.84B in fiscal 2024 and the lowest $548.36M in fiscal 2025.

How is Caris Life Sciences's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Caris Life Sciences it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Caris Life Sciences (CAI) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/CAI/total-liabilities

Underlying data: Yahoo Finance.